Skip to content

Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial

Testing a Computerized Interactive Stress Management Intervention in Early Stage Cancer: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02939612
Enrollment
200
Registered
2016-10-20
Start date
2016-10-31
Completion date
2025-12-31
Last updated
2025-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Stress, Psychological

Keywords

Stress management, App

Brief summary

The purpose with this study is to test the effect of an app for stress management among patients with a variety of cancer diagnoses.

Detailed description

A cancer diagnosis and subsequent treatment can be disruptive and traumatic, often accompanied by a multitude of stressors for the patients and their support network. Uncertainty of outcome and invasive medical procedures with aversive side effects are not uncommon, and while people differ widely in how they experience and cope with such challenges, cancer related distress including anxiety, depression, worry and rumination is prevalent. With multiple domains of function impacted it is also not surprising that quality of life (QoL) often is diminished. Stress management interventions can facilitate adjustment to cancer, including reduced distress and improved quality of life. Unfortunately, many people with cancer do not have the strength or opportunity to attend groups or in-person interventions. This study will therefore test the effect of an app for stress management among patients with different cancer diagnosis. The app contains 10 modules distributed over five weeks, focusing on education of different techniques for reduction of stress and stress reduction exercises. The app was tested in a feasibility pilot study among 25 patients with a variety of cancer diagnoses and is now being tested in a randomized controlled trial with a sample of 175 cancer survivors. The participants were randomly assigned to use the 10 module app or to a control group that receive treatment as usual, and will be followed with repeated measures over 12 months.

Interventions

BEHAVIORALApp for stress management

An app consisting of 10 modules that teaches stress management, cognitive behavioral coping skills and relaxation training.

Sponsors

Norwegian Cancer Society
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with cancer (all diagnosis). * Maximum time since completed treatment at hospital: 12 months * Patients are \> 18 years of age, able to write/read/speak Norwegian and have their own smart phone or tablet

Exclusion criteria

• None

Design outcomes

Primary

MeasureTime frameDescription
The Perceived Stress Scale (PSS-14)Baseline, post intervention follow up at 3, 6, and 12 months14 item scale measuring perceived stress. Scale range: 0-56. Higher scores indicate higher perceived stress.

Secondary

MeasureTime frameDescription
The Self-Regulatory Fatigue-18 (SRF-18)Baseline, post intervention follow up at 3 and 12 months18 item scale measuring self-regulation. Scale range: 18 to 90. A higher score indicates higher self regulatory fatigue
The Brief Coping Orientation to Problems (Brief COPE)BaselineThe outcome measure consists of 14 different scales of different coping strategies with two items per scale, for a total of 28 items. Scale range 2 to 8. Higher scores indicate higer use of the different coping strategies
Health, well-being and sleepBaseline, post intervention follow up at 3, 6, and 12 monthsA 5 item measure, measuring health, well-being and sleep on a scale from 0 to 10. Higher scores indicate better health, well-being and sleep
SF-36 Item Short Form Health Survey (RAND-36 version)Baseline, post intervention follow up at 3, 6, and 12 months36 item scale measuring health related quality of life (HRQoL). The scale has 8 subscales and 1 single item score. Scale and single item range: 0 to 100. Higher scores indicate higher HRQoL.
The Hospital Anxiety and Depression Scale (HADS)Baseline, post intervention follow up at 3, 6, and 12 months14 item scale measuring anxiety and depression. The Scale has a total score with a scale range of 0 to 42 and an anxiety (HADS-A) and a depression (HADS-D) subscale, both with scale range of 0 to 21. Higer scores indicate higher level of anxiety and depression
The Distress ThermometerBaseline, post intervention follow up at 3, 6, and 12 monthsOne item scale measuring distress on a scale from 0 to 10. Higer scores indicate higher distress
Intervention commentaryPost intervention (immediately post intervention)A six item brief measure of participant's intervention reactions. The first 3 items gauged participants' program perception on a scale from 1 to 5, with 5 indicating better perception. The next 3 items were open ended questions: \* What did you like best? \* What did you like the least? \* Suggestions for improvement?

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026